(Q33216729)

English

Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma

scientific article

Statements

Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma (English)
Marie-Françoise Avril
Pierre van der Bruggen

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit